Phytochemicals a Noval Approach as Therapeutic in Prostate Cancer Treatment
DOI:
https://doi.org/10.55627/jhd.002.01.0740Keywords:
Prostate Cancer, Apoptosis, Angiogenesis, Phytochemicals, Metastasis, Cell CycleAbstract
Prostate cancer stands as a prominent cause of mortality among men globally. The escalating challenges of resistance, toxicity, and side effects associated with traditional treatments have propelled a shift toward more intensive and aggressive approaches in prostate cancer treatment. The persistent rise in incidence coupled with the inadequacy of conventional therapies in managing advanced prostate cancer necessitates the exploration and development of innovative agents for both the treatment and prevention of this malignancy. The utilization of naturally occurring compounds in chemoprevention has emerged as a promising and cost-effective strategy in recent decades. This approach aims to decrease the incidence and morbidity of prostate cancer (PCa) by inhibiting precancerous events before the onset of clinical disease [28]. Prostate cancer (PCa) presents a substantial opportunity for intervention to prevent or impede its progression. With its high incidence and extended latency, PCa remains an ideal candidate for chemoprevention. Pursuing agents that provide substantial protection against the development of this disease is crucial. The discovery of effective chemopreventive agents could have a considerable impact on disease-related costs, morbidity, and mortality for a significant portion of the population
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Zahra mumtaz, Shazia Perveen, Sumaira Kanwal (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.